Background: Opioid-induced hyperalgesia (OIH) is a phenomenon that causes an increased pain sensitization and perception of pain to noxious stimuli secondary to opioid exposure. While this clinical effect has been described in the surgical setting, it is unclear if OIH occurs in the nonsurgical setting.

Study Question: To review the available literature which evaluated OIH in nonsurgical settings.

Data Sources: A comprehensive literature search was performed using PubMed (January 1946-July 2017) using a variety of keywords for OIH. This review included randomized controlled trials with objectives to identify OIH in the nonsurgical setting. The clinical outcomes of interest were identification of OIH, adverse events, and impact of OIH on opioid consumption.

Results: The search identified 8 studies that fulfilled the criteria. Six studies enrolled healthy male volunteers, 1 study used chronic low-back patients, and another used heroin-dependent treatment-seeking adults. Studies used various opioids and dosages, including remifentanil, alfentanil, fentanyl, morphine, methadone, and buprenorphine. Three primary experimental pain induction models were used to evaluate for OIH. Measured outcomes included hyperalgesia area, pain threshold, and pain tolerance. All 5 studies that used the electrical stimulation model identified OIH as a significant outcome. However, only 2 of 5 studies using the cold pressor model and 1 of 3 studies using the heat pressor model identified OIH. None of the trials explored clinical outcomes, such as effects on opioid consumption.

Conclusions: Most included studies identified OIH as a significant outcome within the nonsurgical setting. However, due to conflicting conclusions and various limitations, the clinical impact of OIH could not be assessed. Clinicians should monitor for effects of OIH in the nonoperative setting because there is insufficient evidence from the available literature to conclude that OIH is consistently observed in this setting.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000734DOI Listing

Publication Analysis

Top Keywords

oih
14
nonsurgical setting
12
identified oih
12
opioid-induced hyperalgesia
8
oih nonsurgical
8
clinical outcomes
8
impact oih
8
model identified
8
oih outcome
8
pressor model
8

Similar Publications

A neural circuit from paratenial thalamic nucleus to anterior cingulate cortex for the regulation of opioid-induced hyperalgesia in male rats.

Neurobiol Dis

December 2024

Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, Hubei, China. Electronic address:

Prolonged use of opioids can lead to increased sensitivity to painful stimuli, a condition referred to as opioid-induced hyperalgesia (OIH). However, the mechanisms underlying this contradictory situation remain unclear. This study elucidates the pivotal role of the paratenial thalamic nucleus (PT)-anterior cingulate cortex (ACC) neuronal circuit in the development of OIH in male rats.

View Article and Find Full Text PDF

New therapeutic strategies for metastatic castration-resistant prostate cancer (mCRPC) have been developed in the past to achieve the best response rates. Most recently, the use of combination therapies has been explored to optimize patient outcomes. Poly(ADP-ribose) polymerase inhibitors (PARPi) may help to treat mCRPC more effectively.

View Article and Find Full Text PDF

Macleaya cordata extract improves egg quality by altering gut health and microbiota in laying hens.

Poult Sci

December 2024

Shandong Provincial Key Laboratory of Animal Nutrition and Efficient Feeding, College of Animal Science and Technology, Shandong Agricultural University, Taian, Shandong 271018, China. Electronic address:

Article Synopsis
  • - The study assessed the impact of various dosages of Macleaya cordata extract (MCE) on the health and performance of laying hens, with groups receiving a control diet or different amounts of MCE (250, 350, and 450 mg/kg).
  • - Results showed that MCE significantly improved egg weight, eggshell thickness, serum cytokine levels, and immune responses, particularly at the 350 mg/kg dosage, indicating enhanced gut health and microbiota balance.
  • - The addition of MCE also influenced gene expression related to immune functions, demonstrating a clear relationship between MCE dosage and beneficial effects on layers' health and intestinal microbial composition.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!